Wolf, Jonas Michel, Bianca Gubert Borges, Pamela Pereira Fagundes, Vinicius de Souza, Aline Brenner, Helena Petek, William Michelon dos Santos, Juçara Gasparetto Maccari, Vania Rohsig, Mohamed Parrini Mutlaq, e Luiz Antonio Nasi. “Adverse Drug Events, Comorbidities, and Older Age Are Statistically More Prevalent in COVID-19 Hospitalized Patients Treated With Remdesivir Than Tocilizumab in a Private Hospital from Southern Brazil”. Clinical and Biomedical Research 43, no. 3 (novembro 29, 2023). Acessado junho 24, 2025. https://seer.ufrgs.br/index.php/hcpa/article/view/129384.